Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database

Abstract
This 10-year prospective observational study in patients with biopsy-proven renal cell carcinoma showed that percutaneous cryoablation was associated with a high disease-specific survival (94%) and... Background Percutaneous cryoablation (PCA) is an increasingly utilized treatment for stage I renal cell carcinoma (RCC), albeit without supportive level I evidence. Purpose Primary objective was to...